These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18955536)

  • 1. Activity of T-705 in a hamster model of yellow fever virus infection in comparison with that of a chemically related compound, T-1106.
    Julander JG; Shafer K; Smee DF; Morrey JD; Furuta Y
    Antimicrob Agents Chemother; 2009 Jan; 53(1):202-9. PubMed ID: 18955536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of T-1106 in a hamster model of yellow Fever virus infection.
    Julander JG; Furuta Y; Shafer K; Sidwell RW
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1962-6. PubMed ID: 17420215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of 2'-C-methylcytidine against yellow fever virus in cell culture and in a hamster model.
    Julander JG; Jha AK; Choi JA; Jung KH; Smee DF; Morrey JD; Chu CK
    Antiviral Res; 2010 Jun; 86(3):261-7. PubMed ID: 20227442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AT-752, a double prodrug of a guanosine nucleotide analog, inhibits yellow fever virus in a hamster model.
    Lin K; Good SS; Julander JG; Weight AE; Moussa A; Sommadossi JP
    PLoS Negl Trop Dis; 2022 Jan; 16(1):e0009937. PubMed ID: 35073319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCX4430, a novel nucleoside analog, effectively treats yellow fever in a Hamster model.
    Julander JG; Bantia S; Taubenheim BR; Minning DM; Kotian P; Morrey JD; Smee DF; Sheridan WP; Babu YS
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6607-14. PubMed ID: 25155605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model.
    Julander JG; Morrey JD; Blatt LM; Shafer K; Sidwell RW
    Antiviral Res; 2007 Feb; 73(2):140-6. PubMed ID: 17049380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleoside Analogs with Antiviral Activity against Yellow Fever Virus.
    Zandi K; Amblard F; Amichai S; Bassit L; Tao S; Jiang Y; Zhou L; Ollinger Russell O; Mengshetti S; Schinazi RF
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sofosbuvir inhibits yellow fever virus in vitro and in patients with acute liver failure.
    Mendes ÉA; Pilger DRB; Santos Nastri ACS; Malta FM; Pascoalino BDS; Carneiro D'Albuquerque LA; Balan A; Freitas LHG; Durigon EL; Carrilho FJ; Rebello Pinho JR
    Ann Hepatol; 2019; 18(6):816-824. PubMed ID: 31594756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice.
    Sidwell RW; Barnard DL; Day CW; Smee DF; Bailey KW; Wong MH; Morrey JD; Furuta Y
    Antimicrob Agents Chemother; 2007 Mar; 51(3):845-51. PubMed ID: 17194832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo.
    de Freitas CS; Higa LM; Sacramento CQ; Ferreira AC; Reis PA; Delvecchio R; Monteiro FL; Barbosa-Lima G; James Westgarth H; Vieira YR; Mattos M; Rocha N; Hoelz LVB; Leme RPP; Bastos MM; Rodrigues GOL; Lopes CEM; Queiroz-Junior CM; Lima CX; Costa VV; Teixeira MM; Bozza FA; Bozza PT; Boechat N; Tanuri A; Souza TML
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007072. PubMed ID: 30699122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo activities of T-705 and oseltamivir against influenza virus.
    Takahashi K; Furuta Y; Fukuda Y; Kuno M; Kamiyama T; Kozaki K; Nomura N; Egawa H; Minami S; Shiraki K
    Antivir Chem Chemother; 2003 Sep; 14(5):235-41. PubMed ID: 14694986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo antiviral properties of sulfated galactomannans against yellow fever virus (BeH111 strain) and dengue 1 virus (Hawaii strain).
    Ono L; Wollinger W; Rocco IM; Coimbra TL; Gorin PA; Sierakowski MR
    Antiviral Res; 2003 Nov; 60(3):201-8. PubMed ID: 14638396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections.
    Gowen BB; Wong MH; Jung KH; Sanders AB; Mendenhall M; Bailey KW; Furuta Y; Sidwell RW
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3168-76. PubMed ID: 17606691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of Dengue and Yellow Fever viruses by heme, cobalt-protoporphyrin IX and tin-protoporphyrin IX.
    Assunção-Miranda I; Cruz-Oliveira C; Neris RL; Figueiredo CM; Pereira LP; Rodrigues D; Araujo DF; Da Poian AT; Bozza MT
    J Appl Microbiol; 2016 Mar; 120(3):790-804. PubMed ID: 26759117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of antibody-based assays for high throughput discovery and mechanistic study of antiviral agents against yellow fever virus.
    Gao Z; Zhang L; Ma J; Jurado A; Hong SH; Guo JT; Rice CM; MacDonald MR; Chang J
    Antiviral Res; 2020 Oct; 182():104907. PubMed ID: 32798604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever.
    Oestereich L; Rieger T; Lüdtke A; Ruibal P; Wurr S; Pallasch E; Bockholt S; Krasemann S; Muñoz-Fontela C; Günther S
    J Infect Dis; 2016 Mar; 213(6):934-8. PubMed ID: 26531247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and molecular characterization of a non-lethal, hamster-viscerotropic strain of yellow fever virus.
    McArthur MA; Xiao SY; Barrett AD
    Virus Res; 2005 Jun; 110(1-2):65-71. PubMed ID: 15845256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis.
    Yamada K; Noguchi K; Komeno T; Furuta Y; Nishizono A
    J Infect Dis; 2016 Apr; 213(8):1253-61. PubMed ID: 26655300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of Yellow Fever Virus replication based on 1,3,5-triphenyl-4,5-dihydropyrazole scaffold: Design, synthesis and antiviral evaluation.
    Fioravanti R; Desideri N; Carta A; Atzori EM; Delogu I; Collu G; Loddo R
    Eur J Med Chem; 2017 Dec; 141():15-25. PubMed ID: 29028528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remdesivir efficacy against yellow fever in a hamster model.
    Julander JG; Bunyan E; Jordan R; Porter DP
    Antiviral Res; 2022 Jul; 203():105331. PubMed ID: 35533777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.